n/a
Article Publish Status: FREE
Abstract Title:

Therapeutic potential of silymarin as a natural iron-chelating agent inβ-thalassemia intermedia.

Abstract Source:

Clin Case Rep. 2022 Jan ;10(1):e05293. Epub 2022 Jan 24. PMID: 35106163

Abstract Author(s):

Nahid Reisi, Nafiseh Esmaeil, Marjan Gharagozloo, Behjat Moayedi

Article Affiliation:

Nahid Reisi

Abstract:

Abnormal iron accumulation in vital organs is one of the major complications ofβ-thalassemia intermedia (β-TI). Silymarin, a flavonolignan isolated from, significantly decreases the serum ferritin levels ofβ-TI patients. This finding suggests silymarin as a safe and effective natural iron-chelating agent for the treatment of iron-overloaded conditions.

Study Type : Human: Case Report
Additional Links
Pharmacological Actions : Iron Chelating Agents : CK(58) : AC(20)

Print Options


Key Research Topics

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2024 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.